Note: Ingredients listed on restricted chemical lists
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
<1
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% 017-002- >=25% <25% >=10%
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
<1
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
*
General Information
Version
3
Revision date
2025-06-16
Product name
Naloxone Hydrochloride Injection, USP (Hospira Inc.)
Product name
Naloxone Hydrochloride Injection, USP (Hospira Inc.)
Identification on the label/Trade name
Naloxone Hydrochloride Injection
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product
Icons in SDS
Company Information
company name
Pfizer New Zealand Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Not classified
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture GHS - Classification: Not classified as hazardous
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Not classified
Hazard statements
Not classified in accordance with international standards for workplace safety.
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Chemical name This product does not contain any known or suspected endocrine disruptors.
2.1 Classification of the substance or mixture
GHS - Classification: Not classified as hazardous. OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable